| |
Home follow-upaN=986
|
Clinic follow-upbN=2932
| |
|---|
|
Patient characteristic
|
Completedc
|
(%)d
|
Completed
|
(%)
|
p-valuee
|
Risk ratiof
|
|---|
|
All patients
|
887
|
(90.0)
|
2147
|
(73.2)
|
<0.001g
|
1.23
|
|
Female
|
500
|
(91.1)
|
1068
|
(72.8)
|
0.99
|
1.25
|
|
Age categories:
| | | | |
<0.001
| |
|
Age<6
|
135
|
(95.7)
|
129
|
(92.1)
| |
1.04
|
|
Age 6 to <18
|
258
|
(93.1)
|
813
|
(84.1)
| |
1.11
|
|
Age 18 to <35
|
347
|
(87.0)
|
685
|
(63.1)
| |
1.38
|
|
Age 35 and older
|
147
|
(87.0)
|
520
|
(70.3)
| |
1.24
|
|
Place of birth:
| | | | |
<0.001
| |
|
Latin America
|
526
|
(88.9)
|
1124
|
(71.5)
| |
1.24
|
|
Asia
|
227
|
(93.4)
|
652
|
(77.9)
| |
1.20
|
|
USA
|
66
|
(88.0)
|
185
|
(69.0)
| |
1.28
|
|
Africa
|
21
|
(95.5)
|
34
|
(70.8)
| |
1.35
|
|
Europe
|
19
|
(95.0)
|
66
|
(80.5)
| |
1.18
|
|
Unknown
|
28
|
(82.4)
|
86
|
(69.4)
| |
1.19
|
|
Patient referral reason:
| | | | |
<0.001
| |
|
Correctional/rehabilitationh
|
7
|
(77.8)
|
106
|
(46.9)
| |
1.66
|
|
TST converters/TB contactsi
|
199
|
(90.5)
|
177
|
(77.3)
| |
1.17
|
|
Postpartum women
|
51
|
(86.4)
|
94
|
(55.6)
| |
1.55
|
|
TST+j from screening
|
630
|
(90.3)
|
1770
|
(76.9)
| |
1.17
|
|
Prescribed 9 months isoniazidk
|
508
|
(91.5)
|
1226
|
(76.9)
|
<0.001
|
1.19
|
-
aPatients assigned home-based follow-up with community health workers and public health nurses.
-
bPatients with only clinic-based follow-up.
-
cCompleted at least 6 months of isoniazid.
-
dPercentage of number completed over total number in category, listed in Table 1.
-
eCochran-Mantel-Haenszel test except as noted, all p-values adjusted for multiple comparisons.
-
fUnadjusted “risk” ratio of completing treatment of home versus clinic follow-up for each patient category.
-
gChi-square test.
-
hPatients from correctional and drug and alcohol rehabilitation facilities.
-
iRecent tuberculin skin test converters and household contacts to active tuberculosis cases.
-
jTST+: Tuberculin skin test positive.
-
kPrescribed 9 months instead of 6 months of isoniazid.
